scispace - formally typeset
Search or ask a question
Institution

Government of India

GovernmentNew Delhi, India
About: Government of India is a government organization based out in New Delhi, India. It is known for research contribution in the topics: Population & Government. The organization has 2945 authors who have published 2999 publications receiving 44942 citations. The organization is also known as: Union Government & Central Government.


Papers
More filters
Journal ArticleDOI
TL;DR: This investigation demonstrates a more rapid and larger extent of transport of clonazepam into the rat brain with intranasal CMME, which may prove useful in treating acute status epileptics.

189 citations

Journal ArticleDOI
TL;DR: The Indian Sub-Continent is one of the most densely populated regions of the world, hosting ∼23% of the global population within only 3% of world's land area as discussed by the authors.

185 citations

Journal ArticleDOI
TL;DR: The phylogenetic analysis has revealed that SARS-CoV-2 has significant sequence similarity with severe acute respiratory syndrome-like (SARS-like) bat viruses, thus bats could be primary possible reservoir of COVID-19.
Abstract: The coronavirus disease (COVID-19) is highly pathogenic viral infection caused by SARS-CoV-2. Currently, COVID-19 has caused global health concern. It is assumed that COVID-19 has zoonotic origin based on the large number of infected people who were exposed to the wet market in Wuhan City, China. The phylogenetic analysis has revealed that SARS-CoV-2 has significant sequence similarity with severe acute respiratory syndrome-like (SARS-like) bat viruses, thus bats could be primary possible reservoir. The intermediate host and there subsequent transfer is not known yet, although human to human transfer is widely confirmed. The transmission of COVID-19 infection from one person to another resulted in the isolation of patients who were subsequently given a variety of treatments. To monitor the current outbreak, robust steps have been taken around the globe to reduce the transmission of COVID-19 infection particularly banning international and domestic flights, inducting lockdowns in vulnerable areas, social distancing etc. No clinically approved antiviral drug or vaccine against COVID-19 is reported yet. However, in clinical trials, few broad-spectrum antiviral drugs were evaluated against COVID-19 infection which resulted in clinical recovery. In this article emergence and pathogenicity of COVID-19 infection along with potential therapeutic strategies are analyzed to combat the COVID-19 pandemic.

176 citations

Journal ArticleDOI
TL;DR: The Government of India will, however, need to introduce specific methods to contain costs, improve the efficiency of spending, increase accountability, and monitor the effect of expenditures on health.

174 citations


Authors

Showing all 2961 results

NameH-indexPapersCitations
M. Santosh103134449846
Rakesh Kumar91195939017
Sankaran Subramanian7433224680
S. V. Subramanian7244417132
Amit Kumar65161819277
Arvind Subramanian6422020452
Rakesh Sharma6067314157
Anil Mishra5517810505
Kaushik Basu5432313030
Pulok K. Mukherjee5429610873
Maharaj K. Bhan5320711841
Kuldeep Singh5143111815
Rakesh Tuli471657497
Dipak Kumar Sahoo472347293
M. Rajeevan461649115
Network Information
Related Institutions (5)
University of Delhi
36.4K papers, 666.9K citations

89% related

Banaras Hindu University
23.9K papers, 464.6K citations

88% related

Indian Institute of Technology Kharagpur
38.6K papers, 714.5K citations

85% related

Council of Scientific and Industrial Research
31.8K papers, 707.7K citations

85% related

Indian Institutes of Technology
40.1K papers, 652.9K citations

84% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20238
202220
2021369
2020321
2019245
2018218